RankAlpha logo
Back to Rankings

ACHV

Achieve Life SciencesC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
Current thesis
The bull case is that the stock already discounts the expected June 2026 CRL, while the real value driver is whether Adare-enabled remediation lets ACHV resubmit in Q4 2026 and still target an H1 2027 launch. Company materials also frame cytisinicline as potentially the first new FDA-approved smoking-cessation therapy in more than two decades, with added vaping optionality [#SEC-8K-2026-05-12].
Posture
Mixed
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta +6.7.
What can break
Execution risk increased with the CEO transition and broader commercial leadership changes during a pre-launch period [#SEC-8K-2026-05-12] [#8-K-2026-06-02].
Momentum
82
Value
41
Sentiment
36
Setup hits (3d)
— · Net —
AI TargetsBase $5.50 · Bull $10.00 · Bear $2.25
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-06-19 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net —
Target $13.80
Why
Momentum82 · Δ7d +6.7
Value41 · Δ7d -0.1
Sentiment36 · Δ7d -5.4
So what
Balanced signals. Wait for confirmation before sizing up.
Setup hits not loaded

Load setup hits to see net bias and recent triggers.

Load setup hits
Lead driver: Momentum · See technicals
Momentum
82
26% active weight
Current posture
7d trendImproving
Δ7d
+6.7
Δ21d
+7.7
Value
41
39% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
0.0
Sentiment
36
34% active weight
Current posture
7d trendSoftening
Δ7d
-5.4
Δ21d
-5.3
Why this grade

Composite grade C. Momentum 82.4 / Value 41.1 / Sentiment 36.3

Fundamentals (TTM)
As of 2026-07-17
Market Cap
$643.67M
Beta
1.83
Shares Out
102.66M
P/E (TTM) · Derived
-5.0
P/S (TTM)
-
P/FCF (TTM) · Derived
-6.59
Rev YoY
-100.0%
EPS YoY
-48.5%
Gross Margin
-
Op Margin
-
Net Debt
-$21.45M
Current Ratio
2.62
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology